Skip to main content
. 2023 Jul 6;108(12):3321–3332. doi: 10.3324/haematol.2023.283426

Figure 1.

Figure 1.

Mutational landscape of subset of patients undergoing haploidentical hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasm (N=90). CMML: chronic myelomonocytic leukemia; MDS/MPN: myelodysplastic/myeloproliferative overlap neoplasm; MDS/MPN-NOS: MDS/MPN-not otherwise specified; MDS/MPN-SF3B1-T: MDS/MPN with SF3B1 mutation and thrombocytosis.